[Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk]

MeSH terms

• Adrenergic beta-Antagonists / therapeutic use
• Amiodarone / therapeutic use
• Anti-Arrhythmia Agents / therapeutic use
• Arrhythmias, Cardiac / etiology*
• Arrhythmias, Cardiac / prevention & control
• Coronary Disease / physiopathology
• Electrocardiography*
• Electrophysiology
• Humans
• Myocardial Infarction / physiopathology
• Risk Factors
• Vasodilator Agents / therapeutic use
• Ventricular Function*